Inhibition of functional osteoblasts with the platelet-derived growth factor receptor (PDGFR) inhibitor imatinib mesylate in androgen-independent prostate cancer (PCa).

被引：0
|
作者：
Mathew, P [1 ]
Yang, J [1 ]
Kim, SJ [1 ]
Fidler, I [1 ]
Bucana, C [1 ]
Troncoso, P [1 ]
Wang, X [1 ]
Thall, P [1 ]
Logothetis, C [1 ]
Navone, N [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4625
引用
收藏
页码：413S / 413S
页数：1
相关论文
共 50 条
  • [21] Inhibition of androgen-independent growth of prostate cancer xenografts by 17β-estradiol
    Corey, E
    Quinn, JE
    Emond, MJ
    Buhler, KR
    Brown, LG
    Vessella, RL
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1003 - 1007
  • [22] Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor α and akt inactivation
    Matei, D
    Chang, DD
    Jeng, MH
    CLINICAL CANCER RESEARCH, 2004, 10 (02) : 681 - 690
  • [23] Myc is essential for transformation by TEL/platelet-derived growth factor receptor β (PDGFRβ)
    Bourgeade, MF
    Défachelles, AS
    Cayre, YE
    BLOOD, 1998, 91 (09) : 3333 - 3339
  • [24] Preoperative platelet-derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation in high-risk localized prostate cancer
    Mathew, P.
    Pettaway, C.
    Pisters, L.
    Williams, D.
    Troncoso, P.
    Logothetis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Androgen receptor silencing inhibits growth of androgen-independent LNCaP prostate cancer variants
    Mack, Philip C.
    Burich, Rebekah A.
    White, Ralph W. Devere
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells
    Hsieh, Chen-Lin
    Cai, Changmeng
    Giwa, Ahmed
    Bivins, Aaronica
    Chen, Shao-Yong
    Sabry, Dina
    Govardhan, Kumara
    Shemshedini, Lirim
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2008, 41 (1-2) : 13 - 23
  • [27] Imatinib Mesylate Attenuates Myocardial Remodeling Through Inhibition of Platelet-Derived Growth Factor and Transforming Growth Factor Activation in a Rat Model of Hypertension
    Jang, Sung-Won
    Ihm, Sang-Hyun
    Choo, Eun-Ho
    Kim, Ok-Ran
    Chang, Kiyuk
    Park, Chan-Seok
    Kim, Hee-Yeol
    Seung, Ki-Bae
    HYPERTENSION, 2014, 63 (06) : 1228 - 1234
  • [28] Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo
    McGary, EC
    Onn, A
    Mills, L
    Heimberger, A
    Eton, O
    Thomas, GW
    Shtivelband, M
    Bar-Eli, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (02) : 400 - 405
  • [29] Modulation of transforming growth factor β to platelet-derived growth factor receptor-a of human osteoblasts
    杨德鸿
    金大地
    陈建庭
    景宗森
    武大林
    中华医学杂志(英文版), 2000, (07) : 45 - 48
  • [30] Modulation of transforming growth factor β to platelet-derived growth factor receptor-α of human osteoblasts
    Yang, DH
    Jin, DD
    Chen, JT
    Jing, ZS
    Wu, DL
    CHINESE MEDICAL JOURNAL, 2000, 113 (07) : 621 - 624
12345